Safety and Efficacy Results from CLI120-001 a Phase 1 Study in RR-AML and HR-MDS: Update from Higher Dose Levels

Maranda, EL; Patkowska, E; Jakacka, N; Abboud, CN; Burris, HA; Solomon, SR; Angelosanto, N; Rzymski, T; Littlewood, P; Kus, K; Sroka-Porada, A; Dudziak, R; Nogai, H; Glasmacher, A; Bradley, T; Borthakur, G; Mouhayar, E; Steckiewicz, P; Kosciólek-Zgódka, S; Szymanska, A; Zaucha, JM

BLOOD, 2023; 142 ():